Research Roundup

Debbie Rigby rounds up the latest in research news Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis Among participants with obesity and knee osteoarthritis with moderate-to-severe pain, treatment with once-weekly injectable semaglutide resulted in significantly greater reductions in body weight and pain related to knee osteoarthritis than placebo. New England Journal of Medicine, 2024